What is the recommended starting dose of atomoxetine (Strattera) for a 90kg adult male with Attention Deficit Hyperactivity Disorder (ADHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atomoxetine Dosing for a 90kg Adult Male with ADHD

Start atomoxetine at 40 mg once daily, then increase after a minimum of 3 days to the target dose of 80 mg daily, with the option to escalate to a maximum of 100 mg daily after 2-4 additional weeks if response is suboptimal. 1

Initial Dosing Protocol

  • Begin with 40 mg once daily for adults and adolescents over 70 kg 1
  • This starting dose applies regardless of the patient's specific weight above 70 kg 1
  • The medication can be taken with or without food 1
  • Administer as either a single morning dose or split into evenly divided doses (morning and late afternoon/early evening) 1

Dose Escalation Strategy

  • After a minimum of 3 days, increase to the target dose of 80 mg daily 1
  • If inadequate response after 2-4 additional weeks at 80 mg, escalate to the maximum dose of 100 mg daily 1
  • No data support increased effectiveness at doses higher than 100 mg 1
  • Clinical trials in adults used doses of 60,90, or 120 mg/day, though 120 mg exceeds current FDA-approved maximum 2, 3

Important Dosing Modifications

CYP2D6 considerations are critical for this patient:

  • If the patient is taking strong CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine), maintain the 40 mg starting dose for at least 4 weeks before increasing to 80 mg, and only if symptoms fail to improve and the initial dose is well tolerated 1
  • Approximately 7% of the population are CYP2D6 poor metabolizers who require the same cautious dose escalation 4, 1
  • CYP2D6 status significantly affects drug levels and side effect profile 4

Safety Monitoring Requirements

Before initiating treatment:

  • Screen for personal or family history of bipolar disorder, mania, or hypomania 1

During treatment, monitor:

  • Heart rate and blood pressure (modest increases are common but generally well tolerated) 4, 2
  • Suicidality, clinical worsening, and unusual behavioral changes, especially during the first few months or at dose changes 4
  • Common adverse effects include dry mouth, insomnia, nausea, decreased appetite, constipation, dizziness, sweating, dysuria, sexual problems, and palpitations 2, 3

Clinical Pearls

  • Atomoxetine can be discontinued without tapering 1
  • Capsules must be swallowed whole and should not be opened 1
  • The drug carries negligible abuse potential and is not a controlled substance, making it particularly useful for patients at risk for substance abuse 2, 3
  • Response rates in adult trials showed 28-30% mean reduction in ADHD symptom scores versus 18-20% with placebo 2, 3
  • Withdrawal rates due to adverse events in adult trials ranged from 7.8-9.3% versus 2.4-4.3% with placebo 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.